Abstract:
The first study describes the conversion of sclareolide to C2-functionalized lissoclimide derivatives via key C–H functionalization and asymmetric Evans aldol addition steps. The selectivity of C–H functionalization at the C2 position of sclareolide using various approached is discussed. Additionally, halogen-π interactions within the 80S ribosomal pocket were investigated for all of the novel lissoclimide derivatives.